bpc 157 kpv FDA panel backs compounded BPC-157, peptides in win for RFK Jr BPC-157 + KPV 500/500 mcg

Patients on Tirzepatide 15 mg weekly lost an average of 20.9% or 48.6 lb of their body weight after 72 weeks in the Zepbound Study 1 (NCT04184622) compared to placebo patients who lost an average of 3.1% or 7.2 lb

The effect is localized first and then systemic so although the absorption is much less, its quite effective for the problem being addressed

Visit our website TheReClinic.com or follow us on Instagram @thereclinic to learn more about our services

Researchers should avoid direct exposure through inhalation, ingestion, or skin contact and use suitable protective equipment during handling

This may be more common in people allergic to certain medications that resemble folic acid